Abstract:The overall goal of this article is to demonstrate a state-of-the-art ultrahigh field (UHF) magnetic resonance (MR) protocol of the brain at 7.0 Tesla in multiple sclerosis (MS) patients. MS is a chronic inflammatory, demyelinating, neurodegenerative disease that is characterized by white and gray matter lesions. Detection of spatially and temporally disseminated T2-hyperintense lesions by the use of MRI at 1.5 T and 3 T represents a crucial diagnostic tool in clinical practice to establish accurate diagnosis of MS based on the current version of the 2017 McDonald criteria. However, the differentiation of MS lesions from brain white matter lesions of other origins can sometimes be challenging due to their resembling morphology at lower magnetic field strengths (typically 3 T). Ultrahigh field MR (UHF-MR) benefits from increased signal-to-noise ratio and enhanced spatial resolution, both key to superior imaging for more accurate and definitive diagnoses of subtle lesions. Hence, MRI at 7.0 T has shown encouraging results to overcome the challenges of MS differential diagnosis by providing MS-specific neuroimaging markers (e.g., central vein sign, hypointense rim structures and differentiation of MS grey matter lesions). These markers and others can be identified by other MR contrasts other than T1 and T2 (T2*, phase, diffusion) and substantially improve the differentiation of MS lesions from those occurring in other neuroinflammatory conditions such as neuromyelitis optica and Susac syndrome. In this article, we describe our current technical approach to study cerebral white and grey matter lesions in MS patients at 7.0 T using different MR acquisition methods. The up-to-date protocol includes the preparation of the MR setup including the radio-frequency coils customized for UHF-MR, standardized screening, safety and interview procedures with MS patients, patient positioning in the MR scanner and acquisition of dedicated brain scans tailored for examining MS.

Biochemical and Physiological MR Imaging of Skeletal Muscle at 7 Tesla and Above

Challenges and Opportunities of Ultra-High Field MRI

Cardiac functional magnetic resonance imaging at 7T: Image quality optimization and ultra-high field capabilities

Pros and cons of ultra-high-field MRI/MRS for human application

Improvement of MRS at ultra-high field using a wireless RF array

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

MRI with ultrahigh field strength and high-performance gradients: challenges and opportunities for clinical neuroimaging at 7 T and beyond

Cortical Bone under an Ultrahigh Magnetic Field: Relaxation, Spectroscopy and Micron-resolution Imaging

Characterizing brain mechanics through 7 Tesla magnetic resonance elastography

Unlocking new avenues for non-invasive brain monitoring with combined electroencephalography and functional magnetic resonance imaging at ultra-high field

Ultra-High-Field Imaging of the Pediatric Brain and Spinal Cord

7-Tesla Functional Cardiovascular MR Using Vectorcardiographic Triggering-Overcoming the Magnetohydrodynamic Effect

Ultra‐low‐field magnetization transfer imaging at 0.055T with low specific absorption rate

Leveraging ultra-high field (7T) MRI in psychiatric research

Safety and image quality at 7T MRI for deep brain stimulation systems: Ex vivo study with lead-only and full-systems

Bi-ventricular assessment with cardiovascular magnetic resonance at 5 Tesla: A pilot study

Ultra-high field MRI: Advancing systems neuroscience towards mesoscopic human brain function

Micron‐resolution Imaging of Cortical Bone under 14 T Ultrahigh Magnetic Field

Next-generation MRI scanner designed for ultra-high-resolution human brain imaging at 7 Tesla

3D localized lactate detection in muscle tissue using double-quantum filtered 1 H MRS with adiabatic refocusing pulses at 7 T

B1-MRF: Large dynamic range MRF-based absolute B 1 + mapping in the human body at 7T